Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Heterogeneity in Alzheimer's Disease Diagnosis and Progression Rates: Implications for Therapeutic Trials
Ranjan Duara, Warren Barker
Neurotherapeutics (2022) Vol. 19, Iss. 1, pp. 8-25
Open Access | Times Cited: 75

Showing 1-25 of 75 citing articles:

Regulation of immunomodulatory networks by Nrf2-activation in immune cells: Redox control and therapeutic potential in inflammatory diseases
Tarun Pant, Nnamdi Uche, Matea Juric, et al.
Redox Biology (2024) Vol. 70, pp. 103077-103077
Open Access | Times Cited: 27
Pathogenesis, Diagnostics, and Therapeutics for Alzheimer's Disease: Breaking the Memory Barrier
Pushpa Tryphena Kamatham, Rashi K. Shukla, Dharmendra Kumar Khatri, et al.
Ageing Research Reviews (2024) Vol. 101, pp. 102481-102481
Open Access | Times Cited: 18
Quercetin-functionalized nanomaterials: Innovative therapeutic avenues for Alzheimer's disease management
Jinjin Pei, Ranil Vikraman Kumarasamy, Selvaraj Jayaraman, et al.
Ageing Research Reviews (2025), pp. 102665-102665
Closed Access | Times Cited: 9
Studying Alzheimer’s disease through an integrative serum metabolomic and lipoproteomic approach
Alessia Vignoli, G. Bellomo, Federico Paolini Paoletti, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 3
Impact of NQO1 dysregulation in CNS disorders
Yuhan Li, Maryam Khaleghi Ghadiri, Ali Gorji
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 14
Controversial Past, Splendid Present, Unpredictable Future: A Brief Review of Alzheimer Disease History
Félix Bermejo‐Pareja, Teodoro del Ser
Journal of Clinical Medicine (2024) Vol. 13, Iss. 2, pp. 536-536
Open Access | Times Cited: 10
Decoding the role of the CCL2/CCR2 axis in Alzheimer’s disease and innovating therapeutic approaches: Keeping All options open
Reyhaneh Arfaei, Narges Mikaeili, Fatemeh Daj, et al.
International Immunopharmacology (2024) Vol. 135, pp. 112328-112328
Closed Access | Times Cited: 9
Inducers and modulators of protein aggregation in Alzheimer's disease - Critical tools for understanding the foundations of aggregate structures
Kerry Sun, Sue‐Ann Mok
Neurotherapeutics (2025), pp. e00512-e00512
Closed Access | Times Cited: 1
Decoding microglial immunometabolism: a new frontier in Alzheimer's disease research
Eun Sun Jung, Hayoung Choi, Inhee Mook‐Jung
Molecular Neurodegeneration (2025) Vol. 20, Iss. 1
Open Access | Times Cited: 1
Lipopolysaccharides (LPSs) as Potent Neurotoxic Glycolipids in Alzheimer’s Disease (AD)
Yuhai Zhao, Vivian Jaber, Aileen I. Pogue, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12671-12671
Open Access | Times Cited: 35
Unlocking the Therapeutic Potential of Medicinal Plants for Alzheimer’s Disease: Preclinical to Clinical Trial Insights
Kushagra Nagori, Kartik T. Nakhate, Krishna Yadav, et al.
Future Pharmacology (2023) Vol. 3, Iss. 4, pp. 877-907
Open Access | Times Cited: 22
Occupational Therapy Practice Guidelines for Adults Living With Alzheimer’s Disease and Related Neurocognitive Disorders
Stacy Smallfield, Lizabeth Metzger, Melissa J. Green, et al.
American Journal of Occupational Therapy (2024) Vol. 78, Iss. 1
Open Access | Times Cited: 8
Recent Advances in Therapeutics for the Treatment of Alzheimer’s Disease
Amin Mahmood Thawabteh, Aseel Wasel Ghanem, Sara AbuMadi, et al.
Molecules (2024) Vol. 29, Iss. 21, pp. 5131-5131
Open Access | Times Cited: 8
Meta-analysis of the make-up and properties of in vitro models of the healthy and diseased blood–brain barrier
James G. Shamul, Zhiyuan Wang, Hyeyeon Gong, et al.
Nature Biomedical Engineering (2024)
Closed Access | Times Cited: 7
Comparative interactome mapping of Tau‐protein in classical and rapidly progressive Alzheimer's disease identifies subtype‐specific pathways
Abrar Younas, Neelam Younas, Muhammad Javed Iqbal, et al.
Neuropathology and Applied Neurobiology (2024) Vol. 50, Iss. 1
Open Access | Times Cited: 6
Identification of endoplasmic reticulum stress-associated genes and subtypes for prediction of Alzheimer’s disease based on interpretable machine learning
Yongxing Lai, Xueyan Lin, Chunjin Lin, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 19
Identification of metabolism-related subtypes and feature genes in Alzheimer’s disease
Piaopiao Lian, Xing Cai, Cailin Wang, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 12
Predicting clinical progression trajectories of early Alzheimer's disease patients
Viswanath Devanarayan, Yuanqing Ye, Arnaud Charil, et al.
Alzheimer s & Dementia (2023) Vol. 20, Iss. 3, pp. 1725-1738
Open Access | Times Cited: 12
Embracing Ambiguity and Uncertainty: A Culturally Sensitive Approach to Dementia Care in Latinx Communities
Juan Francisco Flores-Vázquez, Rodrigo Gómez-Martínez, Jordan F. Karp, et al.
Hispanic Journal of Behavioral Sciences (2025)
Closed Access
Natural Products from Plants and Algae for Treatment of Alzheimer’s Disease: A Review
Jana Klose, Carola Griehl, Steffen Roßner, et al.
Biomolecules (2022) Vol. 12, Iss. 5, pp. 694-694
Open Access | Times Cited: 17
Potential multiple disease progression pathways in female patients with Alzheimer’s disease inferred from transcriptome and epigenome data of the dorsolateral prefrontal cortex
Kousei Honda, Akinori Awazu
PLoS ONE (2025) Vol. 20, Iss. 3, pp. e0313733-e0313733
Open Access
Unraveling temporal patterns of diagnostic markers and comorbidities in Alzheimer's disease: Insights from large‐scale data
Bayard Rogers
Alzheimer s & Dementia (2025) Vol. 21, Iss. 3
Open Access
Misclassification in memory modification in AppNL-G-F knock-in mouse model of Alzheimer’s disease
Marilyn Huang, Yusuke Suzuki, Hiroki Sasaguri, et al.
(2025)
Open Access
Misclassification in memory modification in AppNL-G-F knock-in mouse model of Alzheimer’s disease
Marilyn Huang, Yusuke Suzuki, Hiroki Sasaguri, et al.
(2025)
Open Access
Identifying progression subphenotypes of Alzheimer’s disease from large-scale electronic health records with machine learning
Manqi Zhou, Alice Tang, Hao Zhang, et al.
Journal of Biomedical Informatics (2025), pp. 104820-104820
Closed Access
Page 1 - Next Page

Scroll to top